Article Details
Retrieved on: 2024-07-26 21:22:47
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA approval of the JAK inhibitors deuruxolitinib, baricitinib, and ritlecitinib for treating severe alopecia areata, highlighting significant advancements in hair loss treatment. Though unrelated to physics, it is pertinent to human hair and hair diseases.
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here